These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33771621)

  • 1. The potential of porcine ex vivo platform for intestinal permeability screening of FcRn-targeted drugs.
    Azevedo C; Andersen JT; Traverso G; Sarmento B
    Eur J Pharm Biopharm; 2021 May; 162():99-104. PubMed ID: 33771621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron tomography of late stages of FcRn-mediated antibody transcytosis in neonatal rat small intestine.
    Ladinsky MS; Huey-Tubman KE; Bjorkman PJ
    Mol Biol Cell; 2012 Jul; 23(13):2537-45. PubMed ID: 22573886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery.
    Pridgen EM; Alexis F; Kuo TT; Levy-Nissenbaum E; Karnik R; Blumberg RS; Langer R; Farokhzad OC
    Sci Transl Med; 2013 Nov; 5(213):213ra167. PubMed ID: 24285486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis.
    Hornby PJ; Cooper PR; Kliwinski C; Ragwan E; Mabus JR; Harman B; Thompson S; Kauffman AL; Yan Z; Tam SH; Dorai H; Powers GD; Giles-Komar J
    Pharm Res; 2014 Apr; 31(4):908-22. PubMed ID: 24072267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer.
    Porter C; Armstrong-Fisher S; Kopotsha T; Smith B; Baker T; Kevorkian L; Nesbitt A
    J Reprod Immunol; 2016 Aug; 116():7-12. PubMed ID: 27123565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.
    Kliwinski C; Cooper PR; Perkinson R; Mabus JR; Tam SH; Wilkinson TM; Giles-Komar J; Scallon B; Powers GD; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G262-70. PubMed ID: 23220220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of FcRn binding properties on the gastrointestinal absorption and exposure profile of Fc molecules.
    Lawrence SA; Blankenship R; Brown R; Estwick S; Ellis B; Thangaraju A; Datta-Mannan A
    Bioorg Med Chem; 2021 Feb; 32():115942. PubMed ID: 33461147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcRn Expression on Placenta and Fetal Jejunum during Early, Mid-, and Late Gestation in Minipigs.
    Jacobsen B; Hill M; Reynaud L; Hey A; Barrow P
    Toxicol Pathol; 2016 Apr; 44(3):486-91. PubMed ID: 26516163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography.
    He W; Ladinsky MS; Huey-Tubman KE; Jensen GJ; McIntosh JR; Björkman PJ
    Nature; 2008 Sep; 455(7212):542-6. PubMed ID: 18818657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions.
    Sockolosky JT; Tiffany MR; Szoka FC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16095-100. PubMed ID: 22991460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FcRn-Dependent Transcytosis of Monoclonal Antibody in Human Nasal Epithelial Cells In Vitro: A Prerequisite for a New Delivery Route for Therapy?
    Bequignon E; Dhommée C; Angely C; Thomas L; Bottier M; Escudier E; Isabey D; Coste A; Louis B; Papon JF; Gouilleux-Gruart V
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of Polymeric Immunoglobulin Receptor and Neonatal Fc Receptor Expression in the Gut Mucosa of Immunodeficiency Virus-Infected Rhesus Macaques.
    Wang Y; Yang GB
    Scand J Immunol; 2016 Apr; 83(4):235-43. PubMed ID: 26860548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of nanobodies that target human neonatal Fc receptor.
    Andersen JT; Gonzalez-Pajuelo M; Foss S; Landsverk OJ; Pinto D; Szyroki A; de Haard HJ; Saunders M; Vanlandschoot P; Sandlie I
    Sci Rep; 2013; 3():1118. PubMed ID: 23346375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.
    Stapleton NM; Brinkhaus M; Armour KL; Bentlage AEH; de Taeye SW; Temming AR; Mok JY; Brasser G; Maas M; van Esch WJE; Clark MR; Williamson LM; van der Schoot CE; Vidarsson G
    Sci Rep; 2019 May; 9(1):7363. PubMed ID: 31089170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review.
    Fieux M; Le Quellec S; Bartier S; Coste A; Louis B; Giroudon C; Nourredine M; Bequignon E
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs.
    Viuff D; Antunes F; Evans L; Cameron J; Dyrnesli H; Thue Ravn B; Stougaard M; Thiam K; Andersen B; Kjærulff S; Howard KA
    J Control Release; 2016 Feb; 223():22-30. PubMed ID: 26699424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery.
    Azevedo C; Pinto S; Benjakul S; Nilsen J; Santos HA; Traverso G; Andersen JT; Sarmento B
    Adv Drug Deliv Rev; 2021 Aug; 175():113778. PubMed ID: 33887405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn
    Mester S; Evers M; Meyer S; Nilsen J; Greiff V; Sandlie I; Leusen J; Andersen JT
    MAbs; 2021; 13(1):1893888. PubMed ID: 33691596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction with both domain I and III of albumin is required for optimal pH-dependent binding to the neonatal Fc receptor (FcRn).
    Sand KM; Bern M; Nilsen J; Dalhus B; Gunnarsen KS; Cameron J; Grevys A; Bunting K; Sandlie I; Andersen JT
    J Biol Chem; 2014 Dec; 289(50):34583-94. PubMed ID: 25344603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal Fc Receptor Binding Tolerance toward the Covalent Conjugation of Payloads to Cysteine 34 of Human Albumin Variants.
    Petersen SS; Kläning E; Ebbesen MF; Andersen B; Cameron J; Sørensen ES; Howard KA
    Mol Pharm; 2016 Feb; 13(2):677-82. PubMed ID: 26654692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.